TGFB2 and neoplasm: Future studies will require confirmation of mRNA levels validated using qPCR methods, protein levels, and signaling mechanisms to expand on these initial findings, especially utilizing TGFB2 and MGMT methylation screens from patient-derived tumor tissues.